Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times - Wikidata - awgldk - TriplyDB

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

http://www.wikidata.org/entity/Q28275419

about

How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Dysphonic Voice Pattern Analysis of Patients in Parkinson's Disease Using Minimum Interclass Probability Risk Feature Selection and Bagging Ensemble Learning Methods.Relation between Voice Handicap Index (VHI) and disease severity in Iranian patients with Parkinson's disease The safety issues and hardware-related complications of deep brain stimulation therapy: a single-center retrospective analysis of 478 patients with Parkinson's disease.Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.Recurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.Effect of Interpersonal Interaction on Festinating Gait Rehabilitation in Patients with Parkinson's Disease.Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease An economic model of Parkinson's disease: implications for slowing progression in the United States.Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson's disease.Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study.Estimating the lifetime economic burden of Parkinson's disease in Singapore.Experiences of caregivers of people with Parkinson's disease in Singapore: a qualitative analysis.Effects of various factors on sleep disorders and quality of life in Parkinson's disease.Comparison of Self-report and Performance-Based Balance Measures for Predicting Recurrent Falls in People With Parkinson Disease: Cohort Study.Validity and Reliability Study of the Korean Tinetti Mobility Test for Parkinson's Disease.Statistical Models of Parkinson's Disease Progression: Predictive Validity in a 3-Year Follow-up.Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.Investigation of the Pharmaceutical Care in One Elderly Parkinson's Disease Patient with Psychotic Symptoms.The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease

P2860

Q28078491-5DFCFB70-5BD0-4E7D-9683-5F0267C33301 Q30276531-4F48D11D-0DE4-42C0-9761-C45B0E0BD231 Q30355655-92B4C1E8-B9ED-4AAC-B020-AEEFCB38A35D Q30457511-F8BD91D2-BC7D-43DC-B8B3-6404D654CA76 Q33803724-F032AD12-F805-49FE-96C7-609052D00B5A Q33807815-687E8228-A2DA-47F1-94F0-981E70F0F12F Q34301607-6E8F6EC2-CDBE-471E-90A5-48BAEAC493B2 Q34651698-2E0C6005-E66F-4FEE-B635-D04880B7911B Q35772039-DE3D4C7E-EF8E-4B57-AABB-B62870F97475 Q36037830-E6B59057-FB97-4A98-BDAC-37D83EE8F11A Q37382891-0BDF252E-F3AA-4505-8140-A34CC2190E2C Q37491322-EB4EA60F-5FDC-4BB4-9A92-F84D3A8786EA Q37601377-8DD11519-BAD4-4AD4-95C2-494B785E5D34 Q38081100-9DAB66C7-5D02-4A08-AA06-3A441EC3D8F0 Q39328352-06668F8E-2299-4275-AE26-0A33EB8AD2A6 Q39524073-DB89E6B0-FC32-4C55-9A20-17519748D015 Q40016191-3262056E-A202-426A-A3B6-90395ED5C112 Q40458623-BE10A36D-8A63-4207-B8BD-1FA44AC93A09 Q44664066-9E25B813-1F3B-49F6-B954-1F89FAF8FD88 Q47392450-AE765DCA-16BB-4927-A39D-DA7059514E14 Q47975218-D595509D-F2B5-4AC8-BC1B-FBB8D5EA76B8 Q48875510-0012E922-63CD-4545-863B-440D0609652F Q49269710-D4EC436E-C0AF-47B4-B1BB-A4EBCC20D58B Q50241406-DF84901B-D472-4223-A9C4-6255959C75BC Q50640051-C649A66B-4A0F-4F9E-8C0D-16B414B471C8 Q55002124-14554384-47F6-448D-A8D4-BACEF3279317 Q58566132-66A1D229-43B7-49FC-9529-09B145C1A52A

P2860

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

http://www.wikidata.org/entity/Q28275419

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@ast

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@en

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@nl

type

label

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@ast

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@en

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@nl

prefLabel

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@ast

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@en

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@nl

P1433

Q28275419-B67E94A6-E244-4B1D-ADF0-F186F76631CA

P1476

Q28275419-4763C89D-486F-4143-9F42-BC9DC3B06FFE

P2093

Q28275419-035C9C25-9776-41D9-A4DF-238B2ADB68F7

Q28275419-22CDF927-CD2D-4340-8947-C281D10BE010

Q28275419-3483CFC7-CA1B-4566-AF5D-8A258C54CD43

Q28275419-6F1652C5-7CB9-428D-B6ED-393B38FC6753

Q28275419-744C13A2-0D2C-4BD9-8F26-60182B1F1224

Q28275419-9A0022E0-C524-438E-8736-7034FC10EB56

Q28275419-BDB8EA24-5677-49B3-8C0B-06CAC5AFF95E

Q28275419-CC5B4B53-7461-41D9-A1DA-E121F1880FE6

Q28275419-F4C0697F-D457-4A03-A6F1-0EBE221AABCB

P2860

Q28275419-1BD11372-87EB-4891-A073-CC460B3309E8

Q28275419-204C9D18-7C93-42E2-8B4C-B349EE1246E8

Q28275419-2A5A7CD8-2EDC-4E9A-9452-267328A29BCF

Q28275419-3798CAB1-6947-46F5-BB37-3CCE428CFEA6

Q28275419-4F00E10A-7C04-4D33-B9E8-760CCAAA1A62

Q28275419-5448D5AA-3DA2-4D4F-A0FB-7C3FBB674E7F

Q28275419-6C767D16-8F8E-4967-A2E0-3445FAC32038

Q28275419-7B0A1F5E-8C74-4C0C-AAA8-2C37C30D7734

Q28275419-7FA28BD7-FE31-42D1-932C-2510F377C40F

Q28275419-875BEDCF-BDC3-478F-9D3B-356D3991A930

P304

Q28275419-52FCEBC7-D0D5-4A33-8A57-53CEAE6455D5

P31

Q28275419-B959A7DA-6EB3-41D1-AEC4-F57BE63C676A

P3181

Q28275419-4DE49373-B0E9-4E4B-A8B5-58145E620B34

P356

Q28275419-E8008917-6C2A-4991-8FBC-C6AE49BF49D6

P407

Q28275419-20FB4461-228B-464F-82B5-752CD6D5F68E

P433

Q28275419-8BDC81A1-DEE1-42B6-A4A7-4AB0147BE398

P478

Q28275419-3CF89C28-15D9-473A-BAD3-518CE1B70972

P50

Q28275419-50BE8F20-3BE9-4544-B139-0281200F0CD9

P577

Q28275419-9473259B-72AE-4EC6-A75F-12B4A896DA84

P698

Q28275419-05F04D97-A736-44F8-B9EB-ACB48C7FC2B2

P921

Q28275419-611E4688-C723-4A38-9A02-393653E86CC1

P3181

P356

P1433

Movement Disorders

P1476

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

@en

P2093

Emmanuel Camara Pica

http://www.w3.org/2001/XMLSchema#string

Louis C S Tan

http://www.w3.org/2001/XMLSchema#string

Nan Luo

http://www.w3.org/2001/XMLSchema#string

Puay Ngoh Lau

http://www.w3.org/2001/XMLSchema#string

Shu Chuen Li

http://www.w3.org/2001/XMLSchema#string

Soo Hoon Seah

http://www.w3.org/2001/XMLSchema#string

Wing Lok Au

http://www.w3.org/2001/XMLSchema#string

Ying Jiao Zhao

http://www.w3.org/2001/XMLSchema#string

Yiong-Huak Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinsonism: onset, progression and mortality

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Association between early-onset Parkinson's disease and mutations in the parkin gene

Does ageing aggravate parkinsonian disability?

Diagnostic criteria for Parkinson disease.

Medical services utilization and prognosis in Parkinson disease: a population-based study.

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

Mortality of patients with Parkinson's disease treated with levodopa.

An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology.

Effect of age at onset on progression and mortality in Parkinson's disease.

P304

710-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1075189

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/MDS.22875

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20213822

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease